NO2496261T3 - - Google Patents
Info
- Publication number
- NO2496261T3 NO2496261T3 NO10828966A NO10828966A NO2496261T3 NO 2496261 T3 NO2496261 T3 NO 2496261T3 NO 10828966 A NO10828966 A NO 10828966A NO 10828966 A NO10828966 A NO 10828966A NO 2496261 T3 NO2496261 T3 NO 2496261T3
- Authority
- NO
- Norway
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25839109P | 2009-11-05 | 2009-11-05 | |
| PCT/US2010/055068 WO2011056775A2 (fr) | 2009-11-05 | 2010-11-02 | Compositions de cellulose microcristalline et de phosphate de calcium utiles en tant qu'excipients pharmaceutiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO2496261T3 true NO2496261T3 (fr) | 2018-05-19 |
Family
ID=43925704
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO10828966A NO2496261T3 (fr) | 2009-11-05 | 2010-11-02 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8329221B2 (fr) |
| EP (1) | EP2496261B1 (fr) |
| JP (1) | JP6092626B2 (fr) |
| BR (1) | BR112012010400B1 (fr) |
| DK (1) | DK2496261T3 (fr) |
| ES (1) | ES2662698T3 (fr) |
| IL (1) | IL219374B (fr) |
| NO (1) | NO2496261T3 (fr) |
| TW (1) | TWI461213B (fr) |
| WO (1) | WO2011056775A2 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2387993B1 (fr) * | 2010-05-21 | 2012-11-07 | Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi | Comprimés à désintégration orale de zolmitriptan et son procédé de préparation |
| WO2016181228A2 (fr) * | 2015-05-11 | 2016-11-17 | Mybiotix Pharma Ltd. | Systèmes et procédés pour faire croître un biofilm de bactéries probiotiques sur des particules solides pour la colonisation de l'intestin par les bactéries |
| EP4035660A1 (fr) | 2017-10-17 | 2022-08-03 | Synthon B.V. | Comprimés comprenant de la tamsulosine et solifénacine |
| CN108815125A (zh) * | 2018-07-23 | 2018-11-16 | 深圳市优普惠药品股份有限公司 | 微晶纤维素与无水磷酸氢钙复合物及其制备工艺 |
| EP3860572A1 (fr) | 2018-10-04 | 2021-08-11 | Chemische Fabrik Budenheim KG | Billes sphériques pour utilisation dans la production de granulés pharmaceutiquement actifs |
| EP3892262A1 (fr) | 2020-04-06 | 2021-10-13 | Chemische Fabrik Budenheim KG | Billes comprenant un système de tampon |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0047734A1 (fr) | 1980-03-10 | 1982-03-24 | Edward Mendell Co., Inc. | Composition de vehicule pharmaceutique et son procede de production |
| US4517179A (en) | 1983-04-29 | 1985-05-14 | Pennwalt Corporation | Rapid dissolving, uniform drug compositions and their preparation |
| CA1261261A (fr) * | 1985-03-08 | 1989-09-26 | Dev K. Mehra | Composition microcristalline de cellulose et de carbonate de calcium cotraites, et sa preparation |
| US4744987A (en) * | 1985-03-08 | 1988-05-17 | Fmc Corporation | Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation |
| US5585115A (en) * | 1995-01-09 | 1996-12-17 | Edward H. Mendell Co., Inc. | Pharmaceutical excipient having improved compressability |
| US6936277B2 (en) | 1995-01-09 | 2005-08-30 | J. Rettenmaier & Soehne Gmbh & Co. Kg | Pharmaceutical excipient having improved compressibility |
| US6395303B1 (en) * | 1996-06-10 | 2002-05-28 | Edward Mendell Co., Inc. | Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose |
| US6123964A (en) | 1995-10-27 | 2000-09-26 | Merck & Co., Inc. | Wet granulation formulation of a growth hormone secretagogue |
| US5858409A (en) | 1996-04-17 | 1999-01-12 | Fmc Corporation | Hydrolyzed cellulose granulations for pharmaceuticals |
| US5747067A (en) | 1996-12-06 | 1998-05-05 | Fmc Corporation | Co-processed products |
| US6103260A (en) * | 1997-07-17 | 2000-08-15 | Mcneil-Ppc, Inc. | Simethicone/anhydrous calcium phosphate compositions |
| US6716449B2 (en) * | 2000-02-08 | 2004-04-06 | Euro-Celtique S.A. | Controlled-release compositions containing opioid agonist and antagonist |
| US20010053791A1 (en) * | 2000-03-16 | 2001-12-20 | Babcock Walter C. | Glycogen phosphorylase inhibitor |
| AT5874U1 (de) | 2000-12-29 | 2003-01-27 | Bioorg Bv | Pharmazeutische zubereitungen enthaltend amlodipinmaleat |
| EP1226818A1 (fr) | 2001-01-26 | 2002-07-31 | Pfizer Products Inc. | Formulation pharmaceutique présentant des propriétés de cohesion et de compressibilité améliorées |
| DE60306120T2 (de) * | 2002-02-14 | 2006-11-09 | Glaxo Group Ltd., Greenford | Pharmazeutische formulierung, die n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydro-2h-(1,3)oxazino(3,2-a)indol-10-carboxamid oder ein entsprechendes salz hiervon enthält, sowie deren herstellungsprozess, welcher trockengranulierung beinhaltet |
| TW200403994A (en) | 2002-04-04 | 2004-03-16 | Bristol Myers Squibb Co | Oral administration of EPOTHILONES |
| GB0211620D0 (en) | 2002-05-21 | 2002-07-03 | Bioprogress Technology Ltd | Powder compaction and enrobing |
| GB0322358D0 (en) | 2003-09-24 | 2003-10-22 | Bioprogress Technology Ltd | Improvements in powder compaction and enrobing |
| JP3841804B2 (ja) | 2003-10-15 | 2006-11-08 | 富士化学工業株式会社 | 口腔内速崩壊性錠剤用の組成物 |
| AU2005286288A1 (en) | 2004-09-24 | 2006-03-30 | Bioprogress Technology Limited | Additional improvements in powder compaction and enrobing |
| DE102005046146A1 (de) * | 2005-02-25 | 2006-08-31 | Bayerische Motoren Werke Ag | Teilintegralbremse für ein Motorrad |
| US20090215744A1 (en) * | 2005-11-18 | 2009-08-27 | Astrazeneca Ab | Solid Formulations |
| US7998505B2 (en) | 2006-10-27 | 2011-08-16 | Fmc Corporation | Dry granulation binders, products, and use thereof |
| CA2644179C (fr) * | 2007-11-21 | 2018-09-25 | Pharmascience Inc. | Composition pharmaceutique inedite comprenant une matrice de desintegration |
-
2010
- 2010-11-01 TW TW099137531A patent/TWI461213B/zh not_active IP Right Cessation
- 2010-11-02 JP JP2012537933A patent/JP6092626B2/ja active Active
- 2010-11-02 EP EP10828966.1A patent/EP2496261B1/fr active Active
- 2010-11-02 DK DK10828966.1T patent/DK2496261T3/en active
- 2010-11-02 ES ES10828966.1T patent/ES2662698T3/es active Active
- 2010-11-02 US US12/917,904 patent/US8329221B2/en active Active
- 2010-11-02 BR BR112012010400-4A patent/BR112012010400B1/pt active IP Right Grant
- 2010-11-02 WO PCT/US2010/055068 patent/WO2011056775A2/fr active Application Filing
- 2010-11-02 NO NO10828966A patent/NO2496261T3/no unknown
-
2012
- 2012-04-23 IL IL219374A patent/IL219374B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| US20110104288A1 (en) | 2011-05-05 |
| JP6092626B2 (ja) | 2017-03-08 |
| BR112012010400A2 (pt) | 2016-07-12 |
| JP2013510157A (ja) | 2013-03-21 |
| US8329221B2 (en) | 2012-12-11 |
| WO2011056775A3 (fr) | 2011-11-03 |
| BR112012010400B1 (pt) | 2019-11-05 |
| EP2496261A2 (fr) | 2012-09-12 |
| EP2496261A4 (fr) | 2014-03-26 |
| ES2662698T3 (es) | 2018-04-09 |
| IL219374A0 (en) | 2012-06-28 |
| WO2011056775A2 (fr) | 2011-05-12 |
| EP2496261B1 (fr) | 2017-12-20 |
| TW201124157A (en) | 2011-07-16 |
| TWI461213B (zh) | 2014-11-21 |
| IL219374B (en) | 2019-05-30 |
| DK2496261T3 (en) | 2018-03-26 |